Product Images Spironolactone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Spironolactone NDC 17856-2028 by Atlantic Biologicals Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image description - 17856 2028 02
This text provides information about the medication Carospir (spironolactone) in oral suspension form. Each 5 mL of the suspension contains 25mg of spironolactone, delivering 12.5mg per 2.5mL. It is indicated for specific purposes and has a specified dosage schedule, as detailed in the package insert. The medication should be stored at a temperature range of 20°-25°C (68°-77°F) with excursions permitted between 15°-30°C (59°-86°F). The text also mentions the importance of keeping all medications out of the reach of children. The packaging includes a batch number, expiry date, and the manufacturer's details.*
image description - 17856 2028 03
This text is a detailed description of Carospir oral suspension, containing Spironolactone at a strength of 25mg per 5mL, delivering 12.5mg per 2.5mL. It provides instructions to refer to the package insert for indications and dosage schedule, emphasizes oral use only, and storage recommendations between 20°-25°C (68°-77°F) with excursions permitted between 15°-30°C (59°-86°F). The text also mentions keeping the medication out of the reach of children and includes details about the product such as the dosage, quantity, GTIN, expiration date, lot number, and packaging information. Additionally, there is contact information for reordering.*
Structural Formula - spironolactone oral suspension 1
Figure 1 - spironolactone oral suspension 2
This is a graph showing the survival rates by treatment group in a study called RALES. The study compared the effectiveness of Spirorolactone and Placebo treatments on 822 and 841 subjects, respectively. The log-rank p-value is less than 0.001, indicating a significant difference between the two groups in terms of survival rates over the span of 42 months.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
